c-MYC-Independent Nuclear Reprogramming Favors Cardiogenic Potential of Induced Pluripotent Stem Cells

[1]  Timothy J. Nelson,et al.  iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism , 2009, Circulation research.

[2]  R. R. Reijo Pera,et al.  Enhanced Generation of Induced Pluripotent Stem Cells from a Subpopulation of Human Fibroblasts , 2009, PloS one.

[3]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[4]  C. Niu,et al.  c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. , 2009, Blood.

[5]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[6]  Timothy J. Nelson,et al.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. , 2009, Circulation.

[7]  Shinya Yamanaka,et al.  Elite and stochastic models for induced pluripotent stem cell generation , 2009, Nature.

[8]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[9]  Andre Terzic,et al.  Stem Cell Platforms for Regenerative Medicine , 2009, Clinical and translational science.

[10]  Timothy J. Nelson,et al.  Induced Pluripotent Reprogramming from Promiscuous Human Stemness‐Related Factors , 2009, Clinical and translational science.

[11]  Timothy J. Nelson,et al.  Lineage specification of Flk-1+ progenitors is associated with divergent Sox7 expression in cardiopoiesis. , 2009, Differentiation; research in biological diversity.

[12]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[13]  K. Hochedlinger,et al.  Epigenetic reprogramming and induced pluripotency , 2009, Development.

[14]  Marcos J. Araúzo-Bravo,et al.  Oct4-Induced Pluripotency in Adult Neural Stem Cells , 2009, Cell.

[15]  L. Fink,et al.  Phenotypic correction of murine hemophilia A using an iPS cell-based therapy , 2009, Proceedings of the National Academy of Sciences.

[16]  Timothy J. Nelson,et al.  KCNJ11 knockout morula re-engineered by stem cell diploid aggregation , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[17]  Jim Yang,et al.  Stat3 and c-Myc Genome-Wide Promoter Occupancy in Embryonic Stem Cells , 2008, PloS one.

[18]  K. Parker,et al.  Cardiogenesis and the Complex Biology of Regenerative Cardiovascular Medicine , 2008, Science.

[19]  K. Hochedlinger,et al.  Guidelines and techniques for the generation of induced pluripotent stem cells. , 2008, Cell stem cell.

[20]  Timothy J. Nelson,et al.  Stem Cells: Biologics for Regeneration , 2008, Clinical pharmacology and therapeutics.

[21]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[22]  Timothy J. Nelson,et al.  Strategies for Therapeutic Repair: The “R3” Regenerative Medicine Paradigm , 2008, Clinical and translational science.

[23]  Concepcion R. Nierras,et al.  The promise of human induced pluripotent stem cells for research and therapy , 2008, Nature Reviews Molecular Cell Biology.

[24]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[25]  Lars S. Maier,et al.  Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells , 2008, Circulation.

[26]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[27]  Shinya Yamanaka,et al.  Pluripotency and nuclear reprogramming , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[28]  K. Plath,et al.  Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages , 2008, Stem cells.

[29]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[30]  C. Lengner,et al.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. , 2008, Cell stem cell.

[31]  Marius Wernig,et al.  c-Myc is dispensable for direct reprogramming of mouse fibroblasts. , 2008, Cell stem cell.

[32]  G. Galbraith,et al.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state , 2008 .

[33]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[34]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[35]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[36]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[37]  S. Yamanaka.  Strategies and new developments in the generation of patient-specific pluripotent stem cells. , 2007, Cell stem cell.

[38]  D. K. Arrell,et al.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair , 2007, The Journal of experimental medicine.

[39]  D. K. Arrell,et al.  Stem cells transform into a cardiac phenotype with remodeling of the nuclear transport machinery , 2007, Nature Clinical Practice Cardiovascular Medicine.

[40]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[41]  M. Fishbein,et al.  Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2‐dependent pathway , 2006, The EMBO journal.

[42]  A. Terzic,et al.  Stable benefit of embryonic stem cell therapy in myocardial infarction. , 2004, American journal of physiology. Heart and circulatory physiology.

[43]  A. Terzic,et al.  Structural Adaptation of the Nuclear Pore Complex in Stem Cell–Derived Cardiomyocytes , 2003, Circulation research.

[44]  John L Cleveland,et al.  c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. , 2002, Genes & development.

[45]  M. Fishbein,et al.  Inducible Activation of c-Myc in Adult Myocardium In Vivo Provokes Cardiac Myocyte Hypertrophy and Reactivation of DNA Synthesis , 2001, Circulation research.

[46]  S. Bishop,et al.  The c-myc proto-oncogene regulates cardiac development in transgenic mice , 1990, Molecular and cellular biology.

[47]  B. Nadal-Ginard,et al.  Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. , 1988, Proceedings of the National Academy of Sciences of the United States of America.